Piriformis syndrome, diagnosis and treatment

Muscle and Nerve

Volumn 40, Issue 1, 2009, Pages 10-18

  Kirschner, Jonathan S ^a   Foye, Patrick M ^a   Cole, Jeffrey L ^b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b KESSLER INSTITUTE FOR REHABILITATION   (United States)

Author keywords

Botulinum toxin; Myofascial pain; Nerve compression syndromes; Piriformis syndrome; Sciatica

Indexed keywords

ANESTHETIC AGENT; BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; BUPIVACAINE; CORTICOSTEROID; DEXAMETHASONE; LIDOCAINE; METHYLPREDNISOLONE; PLACEBO; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE;

ANESTHESIA; BUTTOCK; CLINICAL TRIAL; CORTICOSTEROID THERAPY; HUMAN; ISCHIALGIA; MUSCLE STRETCHING; MYALGIA; MYOFASCIAL PAIN; NERVE COMPRESSION; NERVE SHEATH; PHYSIOTHERAPY; PRIORITY JOURNAL; REFERRED PAIN; REVIEW; SCIATIC NERVE;

ADRENAL CORTEX HORMONES; ANESTHETICS, LOCAL; BOTULINUM TOXINS; EXERCISE THERAPY; HUMANS; MUSCULAR DISEASES; NERVE COMPRESSION SYNDROMES; PUBMED; SCIATICA;

EID: 67650225299     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21318     Document Type: Review

References (31)

1. Aoki KR, Guyer B. Botulinum toxin type A and other botulinum toxin serotypes: a comparative review of biochemical and pharmacological actions. Eur J Neurol 2001;8(suppl 5):21-29. (Pubitemid 33757688)
2. Beatty RA. The piriformis muscle syndrome: a simple diagnostic maneuver. Neurosurgery 1994;34:512-514. (Pubitemid 24076999)
3. Benzon HT, Katz JA, Benzon HA, Iqbal MS. Piriformis syndrome: anatomic considerations, a new injection technique, and a review of the literature. Anesthesiology 2003;98:1442-1448. (Pubitemid 36622480)
4. Betts A. Combined fluoroscopic and nerve stimulator technique for injection of the piriformis muscle. Pain Physician 2004;7:279-281. (Pubitemid 38660547)
5. Chang C-W, Shieh S-F, Li C-M, Wu W-T, Chang K-F. Measurement of motor nerve conduction velocity of the sciatic nerve in patients with piriformis syndrome: a magnetic stimulation study. Arch Phys Med Rehabil 2006;87:1371-1375. (Pubitemid 44470766)
6. Childers MK, Wilson DJ, Gnatz SM, Conway RR, Sherman AK. Botulinum toxin type A use in piriformis muscle syndrome: a pilot study. Am J Phys Med Rehabil 2002;81:751-759.
7. Fanucci E, Masala S, Sodani G, Varruciu V, Romagnoli A, Squillaci E, et al. CT-guided injection of botulinic toxin for percutaneous therapy of piriformis muscle syndrome with preliminary MRI results about denervative process. Eur Radiol 2001;11:2543-2548. (Pubitemid 33114915)
8. Fishman LM, Anderson C, Rosner B. BoTox and physical therapy in the treatment of piriformis syndrome. Am J Phys Med Rehabil 2002;81:936-942. (Pubitemid 35351102)
9. Fishman LM, Dombi GW, Michaelson C, Ringel S, Rozbruch J, Rosner B, et al. Piriformis syndrome: diagnosis, treatment and outcome - a 10-year study. Arch Phys Med Rehabil 2002;83:295-301. (Pubitemid 34204808)
10. Fishman LM, Konnoth C, Rozner B. Botulinum neurotoxin type B and physical therapy in the treatment of piriformis syndrome: a dose-finding study. Am J Phys Med Rehabil 2004;83:42-50. (Pubitemid 38031610)
11. Fishman LM, Zybert PA. Electrophysiologic evidence of piriformis syndrome. Arch Phys Med Rehabil 1992;73:359-364.
12. Fishman SM, Caneris OA, Bandman TB, Audette JF, Borsook D. Injection of the piriformis muscle by fluoroscopic and electromyographic guidance. Reg Anesth Pain Med 1998;23:554-559. (Pubitemid 28536664)
13. Kirkaldy-Willis WH, Hill RJ. A more precise diagnosis for low-back pain. Spine 1979;4:102-109.
14. Lang AM. Botulinum toxin type B in piriformis syndrome. Am J Phys Med Rehabil 2004;83:198-202. (Pubitemid 38230671)
15. Lee EY, Margherita AJ, Gierada DS, Narra VR. MRI of piriformis syndrome. Am J Rehabil 2004;183:63-64.
16. McCrory P, Bell S. Nerve entrapment syndromes as a cause of pain in the hip, groin and buttock. Sports Med 1999;27:261-274. (Pubitemid 29219274)
17. Monnier G, Tatu L, Michel F. New indications for botulinum toxin in rheumatology. Joint Bone Spine 2006;73:667-671. (Pubitemid 44918416)
18. Moore KL, Dalley AF. Clinically oriented anatomy. 1999, p 334, 334t, 554-555.
19. Pace JB, Nagle D. Piriformis syndrome. West J Med 1976;124:435-439.
20. Papadapoulos EC, Khan SN. Piriformis syndrome and low back pain: a new classification and review of the literature. Orthop Clin N Am 2004;35:65-71. (Pubitemid 38153092)
21. Parziale JR, Hudgins TH, Fishman LM. The piriformis syndrome. Am J Orthop 1996;25:819-823.
22. Pećina M. Contribution to the etiological explanation of the piriformis syndrome. Acta Anat 1979;105:181-187. (Pubitemid 10195210)
23. Porta M. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm. Pain 2000;85:101-105. (Pubitemid 30110749)
24. Robinson DR. Pyriformis Syndrome: The relation to sciatic pain. Am J Surg 1997;73:355-380.
25. Rodrigue T, Hardy RW. Diagnosis and treatment of piriformis syndrome. Neurosurg Clin N Am 2001;12:311-319.
26. Rossi P, Cardinali P, Serrao M, Parisi L, Bianco F, De Bac S. Magnetic resonance imaging findings in piriformis syndrome: a case report. Arch Phys Med Rehabil 2001;82:519-521. (Pubitemid 32289717)
27. Smith J, Hurdle M-F, Locketz AJ, Wisniewski SJ. Ultrasoundguided piriformis injection: technique description and verification. Arch Phys Med Rehabil 2006;97:1664-1667. (Pubitemid 44821061)
28. Stewart JD. The piriformis syndrome is overdiagnosed. Muscle Nerve 2003;27:244-246.
29. United States Food and Drug Administration. FDA approves Botox to treat severe underarm sweating. Available at: http://www.fda.gov/bbs/topics/answers/ 2004/ANS01301.html. Accessed October 24, 2007.
30. Yeoman W. The relation of arthritis of the sacroiliac joint to sciatica, with an analysis of 100 cases. Lancet 1928;2:1119-1122
31. Yoon SJ, Ho J, Kang HY, Lee SH, Kim, KI, Shin WG, et al. Low-dose botulinum toxin type A for the treatment of refractory piriformis syndrome. Pharmacotherapy 2007;27:657-665. (Pubitemid 46700957)